首页> 外文OA文献 >Comparison of the efficacy and safety of CELBESTA® versus CELEBREX® in patients with rheumatoid arthritis: a 6-week, multicenter, double-blind, double-dummy, active-controlled, randomized, parallel-group, non-inferiority phase 4 clinical trial

【2h】

Comparison of the efficacy and safety of CELBESTA® versus CELEBREX® in patients with rheumatoid arthritis: a 6-week, multicenter, double-blind, double-dummy, active-controlled, randomized, parallel-group, non-inferiority phase 4 clinical trial

机译：Celbesta®与Celebrex®患者患者的疗效和安全性比较了类风湿性关节炎的患者：6周，多中心，双盲，双伪，有效控制，随机，平行组，非劣级阶段4临床试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Hyun-Sook Kim; Won-Ho Choi; Bo Young Kim; Sung Soo Kim; Sang-Il Lee; Sang-Hyon Kim; Sung Jae Choi; Geun-Tae Kim; Jin-Wuk Hur; Myeung-Su Lee; Yun Sung Kim; Seung-Jae Hong;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Comparison of the efficacy and safety of CELBESTA? versus CELEBREX? in patients with rheumatoid arthritis: a 6-week, multicenter, double-blind, double-dummy, active-controlled, randomized, parallel-group, non-inferiority phase 4 clinical trial [J] . Hyun-Sook Kim, Won-Ho Choi, Bo Young Kim, Journal of International Medical Research . 2020,第6期

机译：Celbesta的疗效和安全性比较？与Celebrex？在类风湿性关节炎的患者中：6周，多中心，双盲，双静脉，有效控制，随机，并行组，非劣级阶段4临床试验
2. Comparison of the efficacy and safety profiles of a pelubiprofen versus celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, phase III, non-inferiority clinical trial [J] . In Ah Choi, Han-Joo Baek, Chul-Soo Cho, BMC Musculoskeletal Disorders . 2014,第1期

机译：对类风湿性关节炎患者的Pelubiprofof of对Celecoxib的疗效和安全谱的比较：6周，多中心，随机，双盲，III期，非劣级临床试验
3. Safety and efficacy of oral nemonoxacin versus levofloxacin in treatment of community-acquired pneumonia: A phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled, non-inferiority trial [J] . Yuan Jinyi, Mo Biwen, Ma Zhuang, Journal of microbiology, immunology, and infection: Wei mian yu gan ran za zhi . 2019,第1期

机译：口服Nemonxacin的安全性和疗效与左氧氟沙星治疗社区获得的肺炎：第3阶段，多中心，随机，双盲，双伪，主动控制，非劣势试验
4. Efficacy and safety of novel collagen conduits filled with collagen filaments to treat patients with peripheral nerve injury: A multicenter, controlled, open-label clinical trial [D] . Saeki Masaomi, 佐伯将臣 2019

机译：充满胶原细丝的新型胶原蛋白导管治疗周围神经损伤患者的疗效和安全性：一项多中心，对照，开放标签的临床试验
5. Comparison of the efficacy and safety of CELBESTA® versus CELEBREX® in patients with rheumatoid arthritis: a 6-week multicenter double-blind double-dummy active-controlled randomized parallel-group non-inferiority phase 4 clinical trial [O] . Hyun-Sook Kim, Won-Ho Choi, Bo Young Kim, 2020

机译：比较CELBESTA®和CELEBREX®在类风湿关节炎患者中的疗效和安全性：一项为期6周多中心双盲双虚拟主动控制随机平行分组非劣效性的4期临床试验
6. Comparison of the efficacy and safety profiles of a pelubiprofen versus celecoxib in patients with rheumatoid arthritis: a 6-week, multicenter, randomized, double-blind, phase III, non-inferiority clinical trial [O] . 2014

机译：培比洛芬和塞来昔布在类风湿关节炎患者中的疗效和安全性比较：一项为期6周，多中心，随机，双盲，III期，非劣效性的临床试验

Comparison of the efficacy and safety of CELBESTA® versus CELEBREX® in patients with rheumatoid arthritis: a 6-week, multicenter, double-blind, double-dummy, active-controlled, randomized, parallel-group, non-inferiority phase 4 clinical trial

著录项

相似文献

相关主题

期刊订阅